PRIMECAP Management acquired 5.06 Million BeiGene Ltd shares worth $934 Million. That's 0.75% of their equity portfolio (40th largest holding). The investor owns 4.62% of the outstanding BeiGene Ltd stock. The first BeiGene Ltd trade was made in Q2 2017. Since then PRIMECAP Management bought shares seventeen more times and sold shares on fourteen occasions. The investor's estimated purchase price is $979 Million, resulting in a loss of 4.6%.